Stockreport

Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation [Yahoo! Finance]

Ampio Pharmaceuticals, Inc.  (AMPE) 
US:NASDAQ Investor Relations: ampiopharma.com
PDF previously disclosed in its Annual Report on Form 10-K for the year ended December 31, 2023 , which was filed on March 27, 2024 with the Securities and Exchange Commissi [Read more]